Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Helixate FS
- Development stage
- Approved
- Lead developer
- CSL Behring
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intravenous
01
Overview
Helixate FS is a recombinant antihemophilic factor (Factor VIII) therapy developed and marketed by CSL Behring for the treatment of hemophilia A. It is a second-generation recombinant Factor VIII product produced using recombinant DNA technology in baby hamster kidney (BHK) cells. The drug functions by replacing the deficient or defective clotting Factor VIII in patients, thereby restoring the intrinsic pathway of the coagulation cascade and enabling effective clot formation. Helixate FS was indicated for the on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis to reduce bleeding frequency and joint damage in both adults and children. The product was manufactured by Bayer for CSL Behring and was phased out globally after December 2017 as CSL Behring transitioned its portfolio toward next-generation hemophilia treatments.
- Brand names
- Helixate FSHelixate NexGen
- Other names
- octocog alfaRecombinant Antihemophilic FactorRecombinant Factor VIIIrFVIII
02
Targets
F8 (Coagulation Factor VIIIa)
Beyond the preview
Go deeper on Helixate FS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Helixate FS.